MSF report shows price of older HIV drugs decreasing, but salvage regimens are 18 times more expensive than first-line treatment
Pressure on India’s ‘pharmacy of the developing world’ poses major threat to access to medicines. Read more
R&D REPORT: LIVES ON THE EDGE
MSF illustrates how our staff and patients are impacted by the way biomedical R&D is conducted today, and looks at a broad range of policies aimed at changing this dynamic.
READ THE REPORT
TPP: A BAD DEAL FOR MEDICINE
After 5 years of secret negotiations the US and 11 other Pacific countries have reached an agreement on the full text of the TPP which will now be submitted to national processes for final signature and ratification. Read MSF's reaction.
HIV REPORT: MAKING VIRAL LOAD ROUTINE
The report aims to share practical lessons learnt from MSF’s UNITAID-funded HIV viral load initiative, which has since 2013 supported the scale-up of viral load testing in seven countries.
READ THE REPORT
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond. We are a multi-disciplinary team that includes doctors, pharmacists, scientists, lawyers, as well as advocacy and communications experts. We also work with patient groups and other civil society organisations in response to their concerns over access to treatment.
Stories from the Field
- » Snakebite in South Sudan: Little hope of a cure for the most vulnerable
- » South Sudan: The Book that Traveled Too Much
- » Guinea: Screening for HIV in Conakry
- » Pakistan: Stories from patients cured from hepatitis C in MSF's Machar Clinic in Karachi
- » Chechnya: New Treatment Regimens Giving Hope to XDR TB Patients
- » Yemen: antiretroviral treatment beneath the bombs